Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
Emma Groarke, Associate Research Physician at the National Institutes of Health, shared on LinkedIn:
”Super excited to see our review on VEXAS syndrome now out in The Lancet Group.
Since VEXAS was first discovered at The National Institutes of Health five years ago, we have developed a large multidisciplinary clinical program encompassing National Heart, Lung, and Blood Institute and National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) seeing patients in our combined hematology and rheumatology clinic and developing therapeutic strategies.
While progress has been made, there is much left learn and discover for our patients.
Alice Fike, Peter Grayson, Bhavisha Patel, Kaitlin Quinn, Benjamin Turturice”
Read the full article here.
Article: VEXAS syndrome: a comprehensive review of pathogenesis, clinical spectrum, and therapeutic strategies
Authors: Emma Groarke, Benjamin Turturice, Bhavisha A. Patel, Kaitlin A. Quinn, Alice Fike, Peter C. Grayso
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 3, 2026, 15:42Manuel De Jesus: Innovating Anemia Monitoring Through Biomedical Engineering and Digital Technology
-
Sep 3, 2026, 15:37Hadis Nabipoor: QICL2026 Highlights the Critical Importance of Transfusion Safety
-
Sep 3, 2026, 15:32Gopal Patidar: The ISBT Haemovigilance Working Party Sharing Knowledge and Promoting Best Practices
-
Sep 3, 2026, 15:24Bhalchandra Kawdikar: FDA Approves Rusfertide for Polycythemia Vera
-
Sep 3, 2026, 15:18Massimo Martino: Redefining Allogeneic Transplantation in Myelofibrosis
-
Sep 3, 2026, 15:10Tvisha Subhasish: Extravascular Factor IX Beyond the Circulation
-
Sep 3, 2026, 11:21Thrombotic Microangiopathies: From Clinical Syndrome to Molecularly Targeted Therapy
-
Sep 3, 2026, 10:56Elias Othman: Can an Enzyme Involved in Cell Signaling Become a Target for Antithrombotic Drug Discovery?
-
Sep 3, 2026, 10:42Jared Griffard: Hemorrhagic Shock and Component Blood Transfusion